Company Filing History:
Years Active: 2012-2015
Title: Frank Ploeger: Innovator in Biopharmaceuticals
Introduction
Frank Ploeger is a notable inventor based in Heidelberg, Germany. He has made significant contributions to the field of biopharmaceuticals, particularly in the development of growth factor mutants and methods for tissue regeneration. With a total of 4 patents, his work has the potential to impact various medical applications.
Latest Patents
Among his latest patents, one focuses on high activity growth factor mutants. This invention relates to novel biosynthetic growth factor mutants that exhibit improved biological activity. Another significant patent is a method for inducing tissue growth, differentiation, and/or regeneration by delivering a GDF-5 related precursor protein. This invention involves the production and use of pharmaceutical growth factor compositions with improved solubility and controlled release characteristics under physiological conditions. These compositions can provoke morphogenic effects such as growth, differentiation, protection, and regeneration of various tissues and organs, including bone, cartilage, tendons, ligaments, nerves, and skin. They can be particularly beneficial for healing tissue-destructive injuries and for the prevention or therapy of degenerative disorders.
Career Highlights
Frank Ploeger is associated with Biopharm Gesellschaft zur Biotechnologischen Entwicklung von Pharmaka mbH, where he continues to innovate in the field of biotechnology. His work has garnered attention for its potential applications in regenerative medicine and tissue engineering.
Collaborations
He collaborates with notable colleagues such as Jens Pohl and Michael Kruse, contributing to a dynamic research environment that fosters innovation and development in biopharmaceuticals.
Conclusion
Frank Ploeger's contributions to the field of biopharmaceuticals through his innovative patents and collaborations highlight his role as a key figure in advancing medical science. His work continues to pave the way for new treatments and therapies that can significantly improve patient outcomes.